Page last updated: 2024-10-16

quinacrine and Genetic Non-Disjunction

quinacrine has been researched along with Genetic Non-Disjunction in 1 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Research Excerpts

ExcerptRelevanceReference
"Quinacrine was found to ameliorate the skewed sex ratio but did not affect non-disjunction."1.29Ageing before mating and quinacrine ameliorate the expression of abnormal oocyte (abo) in homozygous Drosophila melanogaster females. ( Magnusson, J; Onfelt, A; Wikén, M, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Onfelt, A1
Magnusson, J1
Wikén, M1

Other Studies

1 other study available for quinacrine and Genetic Non-Disjunction

ArticleYear
Ageing before mating and quinacrine ameliorate the expression of abnormal oocyte (abo) in homozygous Drosophila melanogaster females.
    Hereditas, 1993, Volume: 118, Issue:1

    Topics: Aging; Animals; Drosophila melanogaster; Female; Gene Expression; Male; Mutation; Nondisjunction, Ge

1993